BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27994454)

  • 1. The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro.
    Kasper JY; Hermanns MI; Cavelius C; Kraegeloh A; Jung T; Danzebrink R; Unger RE; Kirkpatrick CJ
    Int J Nanomedicine; 2016; 11():6353-6364. PubMed ID: 27994454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Entero-Capillary Barrier Exhibits Altered Inflammatory and Exosomal Communication Pattern after Exposure to Silica Nanoparticles.
    Kasper JY; Hermanns MI; Kraegeloh A; Roth W; Kirkpatrick CJ; Unger RE
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro.
    Leonard F; Collnot EM; Lehr CM
    Mol Pharm; 2010 Dec; 7(6):2103-19. PubMed ID: 20809575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effect of Kaempferol on LPS-Induced Inflammation and Barrier Dysfunction in a Coculture Model of Intestinal Epithelial Cells and Intestinal Microvascular Endothelial Cells.
    Bian Y; Dong Y; Sun J; Sun M; Hou Q; Lai Y; Zhang B
    J Agric Food Chem; 2020 Jan; 68(1):160-167. PubMed ID: 31825618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction.
    Hermanns MI; Kasper J; Dubruel P; Pohl C; Uboldi C; Vermeersch V; Fuchs S; Unger RE; Kirkpatrick CJ
    J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S41-54. PubMed ID: 19793744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.
    Rutella S; Vetrano S; Correale C; Graziani C; Sturm A; Spinelli A; De Cristofaro R; Repici A; Malesci A; Danese S
    J Cell Mol Med; 2011 Mar; 15(3):625-34. PubMed ID: 20158572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-specific effects by cadmium exposure: apical and basolateral treatment in a coculture model of the blood-air barrier.
    Papritz M; Pohl C; Wübbeke C; Moisch M; Hofmann H; Hermanns MI; Thiermann H; Kirkpatrick CJ; Kehe K
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):361-9. PubMed ID: 20399800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of zinc oxide nanoparticles on an in vitro model of the human air-blood barrier.
    Bengalli R; Gualtieri M; Capasso L; Urani C; Camatini M
    Toxicol Lett; 2017 Sep; 279():22-32. PubMed ID: 28709982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures.
    Kasper J; Hermanns MI; Bantz C; Maskos M; Stauber R; Pohl C; Unger RE; Kirkpatrick JC
    Part Fibre Toxicol; 2011 Jan; 8(1):6. PubMed ID: 21272353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linoorbitides and enterolactone mitigate inflammation-induced oxidative stress and loss of intestinal epithelial barrier integrity.
    Almousa AA; Meurens F; Krol ES; Alcorn J
    Int Immunopharmacol; 2018 Nov; 64():42-51. PubMed ID: 30145469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flotillin-involved uptake of silica nanoparticles and responses of an alveolar-capillary barrier in vitro.
    Kasper J; Hermanns MI; Bantz C; Utech S; Koshkina O; Maskos M; Brochhausen C; Pohl C; Fuchs S; Unger RE; Kirkpatrick CJ
    Eur J Pharm Biopharm; 2013 Jun; 84(2):275-87. PubMed ID: 23183446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha.
    Satsu H; Ishimoto Y; Nakano T; Mochizuki T; Iwanaga T; Shimizu M
    Exp Cell Res; 2006 Nov; 312(19):3909-19. PubMed ID: 17010338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol improves TNF-α-induced endothelial dysfunction in a coculture model of a Caco-2 with an endothelial cell line.
    Toaldo IM; Van Camp J; Gonzales GB; Kamiloglu S; Bordignon-Luiz MT; Smagghe G; Raes K; Capanoglu E; Grootaert C
    J Nutr Biochem; 2016 Oct; 36():21-30. PubMed ID: 27560195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro co-culture model using Caco-2 and J774A.1 cells to mimic intestinal inflammation.
    Belaid M; Javorovic J; Pastorin G; Vllasaliu D
    Eur J Pharm Biopharm; 2024 Apr; 197():114243. PubMed ID: 38432601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CB
    Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor.
    Zhang H; Kovacs-Nolan J; Kodera T; Eto Y; Mine Y
    Biochim Biophys Acta; 2015 May; 1852(5):792-804. PubMed ID: 25558818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.
    Wang W; Xia T; Yu X
    Inflamm Res; 2015 Jun; 64(6):423-31. PubMed ID: 25917044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
    Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific and endothelial-mediated dysfunction of the alveolar-capillary barrier in response to lipopolysaccharides.
    Janga H; Cassidy L; Wang F; Spengler D; Oestern-Fitschen S; Krause MF; Seekamp A; Tholey A; Fuchs S
    J Cell Mol Med; 2018 Feb; 22(2):982-998. PubMed ID: 29210175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.